Clinics and Research in Hepatology and Gastroenterology
Efficacy and safety of empagliflozin in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
By Shambo Samrat Samajdar, Shashank R Joshi, Gaurab Bhaduri, Show 4 more authorsSanjay Bandyopadhyay
Meta-analysis of randomised trialsInterventions
- Empagliflozin
- SLC5A2
- Metabolic dysfunction-associated steatotic liver disease
- Alanine aminotransferase
- APRI
- Humans
The paper
Therapeutics Specialty Clinic Kolkata; Department of Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, 5 Aug 2026
